Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer. uri icon

authors

  • Daneshmand, Siamak
  • Chang, Sam S
  • Catto, James W F
  • Sarah P. Psutka MD MS
  • Guerrero-Ramos, Félix
  • Xylinas, Evanguelos
  • Miyake, Makito
  • Simone, Giuseppe
  • Daniel, Karen
  • Sweiti, Hussein
  • Cutie, Christopher
  • Kamat, Ashish M
  • Necchi, Andrea
  • Shore, Neal D
  • Meeks, Joshua J
  • Galsky, Matthew D
  • Jacob, Joseph M
  • van der Heijden, Michiel S
  • Williams, Stephen B
  • Powles, Thomas

publication date

  • January 15, 2025